Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

False leukemia–lymphoma cell lines: an update on over 500 cell lines

Leukemia volume 17, pages 416–426 (2003)Cite this article

Abstract

Human leukemia–lymphoma (LL) cell lines represent an extremely important resource for research in a variety of fields and disciplines. As the cell lines are used as in vitro model systems in lieu of primary cell material, it is crucial that the cells in the culture flasks faithfully correspond to the purported objects of study. Obviously, proper authentication of cell line derivation and precise characterization are indispensable requirements to use as model systems. A number of studies has shown an unacceptable level of LL cell lines to be false. We present here the results of authenticating a comprehensively large sample (n = 550) of LL cell lines mainly by DNA fingerprinting and cytogenetic evaluation. Surprisingly, near-identical incidences (ca 15%) of false cell lines were observed among cell lines obtained directly from original investigators (59/395: 14.9%) and from secondary sources (23/155: 14.8%) implying that most cross-contamination is perpetrated by originators, presumably during establishment. By comparing our data with those published, we were further able to subclassify the false cell lines as (1) virtual: cross-contaminated with and unretrievably overgrown by other cell lines during initiation, never enjoying independent existence; (2) misidentified: cross-contaminated subsequent to establishment so that an original prototype may still exist; or (3) misclassified: unwittingly established from an unintended (often normal) cell type. Prolific classic leukemia cell lines were found to account for the majority of cross-contaminations, eg CCRF-CEM, HL-60, JURKAT, K-562 and U-937. We discuss the impact of cross-contaminations on scientific research, the reluctance of scientists to address the problem, and consider possible solutions. These findings provide a rationale for mandating the procurement of reputably sourced LL cell lines and their regular authentication thereafter.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Drexler HG (ed.). The Leukemia–Lymphoma Cell Line FactsBook, Academic Press: San Diego 2000.

    Google Scholar 

  2. Drexler HG, Dirks WG, MacLeod RAF . False human hematopoietic cell lines: cross-contaminations and misinterpretations. Leukemia 1999; 13: 1601–1607.

    CAS  PubMed  Google Scholar 

  3. Markovic O, Markovic N . Cell cross-contamination in cell cultures: the silent and neglected danger. In Vitro Cell Dev Biol 1998; 34: 1–8.

    CAS  Google Scholar 

  4. Masters JR . HeLa cells 50 years on: the good, the bad and the ugly. Nature Rev Cancer 2002; 2: 315–319.

    CAS  Google Scholar 

  5. Drexler HG, Uphoff CC, Dirks WG, MacLeod RAF . Mix-ups and mycoplasma: the enemies within. Leukemia Res 2002; 26: 329–333.

    Google Scholar 

  6. Drexler HG, Häne B, Hu ZB, Uphoff CC . HeLa cross-contamination of a leukemia cell line. Leukemia 1993; 7: 2077–2078.

    CAS  PubMed  Google Scholar 

  7. Gignac SM, Steube K, Schleithoff L, Janssen JWG, MacLeod RAF, Quentmeier H, Drexler HG . Multiparameter approach in the identification of cross-contaminated leukemia cell lines. Leuk Lymphoma 1993; 10: 359–368.

    CAS  PubMed  Google Scholar 

  8. Häne B, Tümmler M, Jäger K, Schleithoff L, Janssen JWG, Drexler HG . Differences in DNA fingerprints of continuous leukemia–lymphoma cell lines from different sources. Leukemia 1992; 6: 1129–1133.

    PubMed  Google Scholar 

  9. Jeffreys AJ, Wilson V, Thein SL . Hypervariable ‘minisatellite’ regions in human DNA. Nature 1985; 314: 67–73.

    CAS  PubMed  Google Scholar 

  10. Zischler H, Nanda I, Schäfer R, Schmid M, Epplen JT . Digoxigenated oligonucleotide probes specific for simple repeats in DNA fingerprinting and hybridization in situ. Hum Genet 1989; 82: 227–233.

    CAS  PubMed  Google Scholar 

  11. Gilbert DA, Reid YA, Gail MA, Pee D, White C, Hay RJ, O’Brien SJ . Application of DNA fingerprints for cell-line individualization. Am J Hum Genet 1990; 47: 499–514.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Jeffreys AJ, Wilson V, Thein SL . Individual-specific ‘fingerprints’ of human DNA. Nature 1985; 316: 76–79.

    CAS  PubMed  Google Scholar 

  13. Dirks W, MacLeod RAF, Jäger K, Milch H, Drexler HG . First searchable database for DNA profiles of human cell lines: sequential use of fingerprint techniques for authentication. Cell Mol Biol 1999; 45: 841–853.

    CAS  PubMed  Google Scholar 

  14. Dirks WG, Drexler HG . Authentication of Cancer Cell Lines by DNA Fingerprinting. In: Langdon S (ed.) Cancer Cell Culture – Methods and Protocols, Humana Press: Totowa, NJ (in press)

  15. Dirks WG, MacLeod RAF, Drexler HG . ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source. In Vitro Cell Dev Biol 1999; 35: 558–559.

    CAS  Google Scholar 

  16. MacLeod RAF, Dirks WG, Reid YA, Hay RJ, Drexler HG . Identity of original and late-passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting. Leukemia 1997; 11: 2032–2038.

    CAS  PubMed  Google Scholar 

  17. MacLeod RAF, Drexler HG . Cytogenetic characterization of Tumor Cell Lines. In: Langdon S (ed.) Cancer Cell Culture – Methods and Protocols, Humana Press: Totowa, NJ (in press)

  18. ISCN. Mitelman F (ed). An International System for Human Chromosome Nomenclature, S Karger: Basel 1995.

  19. MacLeod RAF, Drexler HG . Authentication and Characterization. In: Masters JRW, Palsson BO (eds)Human Cell Culture, Vol. III – Cancer Cell Lines Part 3: Leukemias and Lymphomas, Kluwer Academic Pub: Dordrecht 2000. pp 371–397.

    Google Scholar 

  20. MacLeod RAF, Dirks WG, Kaufmann M, Matsuo Y, Milch H, Drexler HG . Widespread intraspecies cross-contamination of human tumor cell line arising at source. Int J Cancer 1999; 83: 555–563.

    CAS  PubMed  Google Scholar 

  21. MacLeod RAF, Dirks WG, Drexler HG . Persistent use of misidentified cell lines and its prevention. Genes Chromosomes Cancer 2002; 33: 103–105.

    PubMed  Google Scholar 

  22. Findley HW Jr, Cooper MD, Kim TH, Alvarado C, Ragab AH . Two new acute lymphoblastic leukemia cell lines with early B-cell phenotype. Blood 1982; 60: 1305–1309.

    PubMed  Google Scholar 

  23. Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL . Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 1977; 267: 841–843.

    CAS  PubMed  Google Scholar 

  24. Zhang LQ, Downie PA, Goodell WR, McCabe NR, LeBeau MM, Morgan R, Sklar J, Raimondi SC, Miley D, Goldberg A, Lu MM, Montag A, Smith SD . Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia. Leukemia 1993; 7: 1865–1874.

    CAS  PubMed  Google Scholar 

  25. Gazitt Y, HE YJ, Shults K, Stelzer GT, Cohen RJ . Isolation and characterization of an early T-helper/inducer cell line with a unique pattern of surface phenotype, constitutive cytokine secretion and myc oncogene expression. Leukemia 1993; 7: 2034–2044.

    CAS  PubMed  Google Scholar 

  26. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE . Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965; 18: 522–529.

    CAS  PubMed  Google Scholar 

  27. Galili N, Galili U, Ravid Z, Schlesinger M, Goldblum N . Induction of differentiation with phorbol ester in a human T cell line (Be13) expressing both prothymocyte and thymocyte characteristics. Human Lymph Diff 1981; 1: 123–130.

    Google Scholar 

  28. Ravid Z, Goldblum N, Zaizov R, Schlesinger M, Kertes T, Minowada J, Verbi W, Greaves M . Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer 1980; 25: 705–710.

    CAS  PubMed  Google Scholar 

  29. Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, Kubonishi I, Kersey J . Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 1979; 23: 174–180.

    CAS  PubMed  Google Scholar 

  30. Wörmann B, Anderson JM, Liberty JA, Gajl-Peczalska K, Brunning RD, Silberman TL, Arthur DC, LeBien TW . Establishment of a leukemic cell model for studying human pre-B to B cell differentiation. J Immunol 1989; 142: 110–117.

    PubMed  Google Scholar 

  31. Jones DB, Scott CS, Wright DH, Stein H, Beverley PCL, Payne SV, Crawford DH . Phenotypic analysis of an established cell line derived from a patient with Hodgkin’s disease (HD). Hematol Oncol 1985; 3: 133–145.

    CAS  PubMed  Google Scholar 

  32. Greenberg SM, Rosenthal DS, Greeley TA, Tantravahi R, Handin RI . Characterization of a new megakaryocytic cell line: The Dami cell. Blood 1988; 72: 1968–1977.

    CAS  PubMed  Google Scholar 

  33. Handin RI . DAMI cell line. Blood 1997; 89: 4238.

    CAS  PubMed  Google Scholar 

  34. Kávai M, Adány R, Pásti G, Surányi P, Szücs G, Muszbek L, Boján F, Szegedi G . Marker profile, enzyme activity, and function of a human myelomonocytic leukemia cell line. Cell Immunol 1992; 139: 531–540.

    PubMed  Google Scholar 

  35. Lozzio CB, Lozzio BB . Cytotoxicity of a factor isolated from human spleen. J Natl Cancer Inst 1973; 50: 535–538.

    CAS  PubMed  Google Scholar 

  36. Faguet GB, Satya-Prakash KL, Agee JF . Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines. Blood 1988; 71: 422–429.

    CAS  PubMed  Google Scholar 

  37. Zhou M, Zaki SR, Ragab AH, Findley HW . Characterization of a myeloperoxidase mRNA(+) acute lymphoblastic leukemia cell line (EU-1/ALL) established from a child with an apparent case of ALL. Leukemia 1994; 8: 659–663.

    CAS  PubMed  Google Scholar 

  38. Zhou M, Gu L, James CD, He J, Yeager AM, Smith SD, Findley HW . Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia 1995; 9: 1159–1161.

    CAS  PubMed  Google Scholar 

  39. Wagner HJ, Klintworth F, Jabs W, Lange K, Schlegelberger B, Harder L, Feller AC, Bucsky P . Characterization of the novel, pediatric Hodgkin disease-derived cell line HKB-1. Med Ped Oncol 1998; 31: 138–143.

    CAS  Google Scholar 

  40. Morikawa S, Tatsumi E, Baba M, Harada T, Yasuhira K . Two E-rosette-forming lymphoid cell lines. Int J Cancer 1978; 21: 166–170.

    CAS  PubMed  Google Scholar 

  41. Drexler HG, MacLeod RAF, Dirks WG . Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell line. Blood 2001; 98: 3495–3496.

    CAS  PubMed  Google Scholar 

  42. Harris NS . Plasma cell surface antigen on human blood lymphocytes. Nature 1974; 250: 507–509.

    CAS  PubMed  Google Scholar 

  43. Kohn G, Mellman WJ, Moorhead PS, Loftus J, Henle G . Involvement of C group chromosomes in five Burkitt lymphoma cell lines. J Natl Cancer Inst 1967; 38: 209–222.

    CAS  PubMed  Google Scholar 

  44. Nelson-Rees WA, Flandermeyer RR . HeLa cultures defined. Science 1976; 191: 96–97.

    CAS  PubMed  Google Scholar 

  45. Osgood EE, Brooke JH . Continuous tissue culture of leukocytes from human leukemic bloods by application of ‘gradient’ principles. Blood 1955; 10: 1010–1022.

    CAS  PubMed  Google Scholar 

  46. Ohta M, Furukawa Y, Ide C, Akiyama N, Utakoji T, Miura Y, Saito M . Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -S, -M and -K) with capabilities of monocyte–macrophage lineage differentiation and constitutive production of interleukin 1. Cancer Res 1986; 46: 3067–3074.

    CAS  PubMed  Google Scholar 

  47. Sundström C, Nilsson K . Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565–577.

    PubMed  Google Scholar 

  48. Kamamoto T, Okuno T, Sakoda H, Taniguchi Y, Kita K, Yoshida Y, Uchino H . Establishment of two Ph1 chromosome-positive cell lines, KPB-M8 and KPB-M15. Jpn J Clin Oncol 1986; 16: 107–115.

    CAS  PubMed  Google Scholar 

  49. Ohkubo T, Kamamoto T, Kita K, Hiraoka A, Yoshida Y, Uchino H . A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisis. Leukemia Res 1985; 9: 921–926.

    CAS  Google Scholar 

  50. Inglés-Esteve J, Aventin A, Azqueta C, Kádár E, Bothner KM, Amill B, Limón A, García López J . A new human cell line with pre-B cell phenotype and t(5;12). Leukemia 1997; 11: 1040–1044.

    PubMed  Google Scholar 

  51. Banerjee R, Bekesi JG, Tarcsafalvi A, Sperber K, Deak G, Choi HSH, Paronetto F, Holland JF, Acs G . Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proc Natl Acad Sci USA 1992; 89: 9996–10000.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Schneider U, Schwenk HU, Bornkamm G . Characterization of EBV-genome negative ‘Null’ and ‘T’ cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non- Hodgkin lymphoma. Int J Cancer 1977; 19: 621–626.

    CAS  PubMed  Google Scholar 

  53. Matsuo Y, Tomiyasu T, Shirakawa F, Yamashita U, Sagawa K, Yokoyama M, Minowada J . Establishment and characterization of a clonal human T-cell line, MKB-1 derived from a patient with acute myeloblastic leukemia. Human Cell 1989; 2: 423–429.

    CAS  PubMed  Google Scholar 

  54. Drexler HG, Minowada J . Morphological, immunophenotypical and isoenzymatic profiles of human leukemia cells and derived T-cell lines. Hematol Oncol 1989; 7: 115–125.

    CAS  PubMed  Google Scholar 

  55. Chen PM, Chiu CF, Chiou TJ, Maeda S, Chiang H, Tzeng CH, Sugiyama T, Chiang BN . Establishment and characterization of a human monocytoid leukemia cell line, CTV-1. Gann 1984; 75: 660–664.

    CAS  PubMed  Google Scholar 

  56. Sahraoui Y, Perraki M, Theodoropoulou M, Allouche M, Tsapis A, Ammar A, Clemenceau C, Bokogiorgou S, Yacci T, Katrinakis G, Jasmin C, Georgoulias V . Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, JH-, TCRβ-, TCRγ- leukemia cell line (NOI-90). Leukemia 1997; 11: 245–252.

    CAS  PubMed  Google Scholar 

  57. Zheng A, Castren K, Saily M, Savolainen ER, Koistinen P, Vahakangas K . p53 status of newly established acute myeloid leukaemia cell lines. Br J Cancer 1999; 79: 407–415.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Wang C, Curtis JE, Minden MD, McCulloch EA . Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264–269.

    CAS  PubMed  Google Scholar 

  59. Pirruccello SJ, Lang MS, Sanger WG . PBEI: A pre-B acute lymphoblastic leukemia cell line derived from long term bone marrow culture. Blood 1991; 78: 39a.

    Google Scholar 

  60. Tucker KA, Lilly MB, Heck L Jr & Rado TA . Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 1987; 70: 372–378.

    CAS  PubMed  Google Scholar 

  61. Collins SJ, Gallo RC, Gallagher RE . Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977; 270: 347–349.

    CAS  PubMed  Google Scholar 

  62. Mallet MK, Mane SM, Meltzer SJ, Needleman SW . C-myc amplification coexistent with activating N-ras point mutation in the biphenotypic leukemic cell line RED-3. Leukemia 1989; 3: 511–515.

    CAS  PubMed  Google Scholar 

  63. Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J, Katsuno M, Masuda S, Sasaki R, Fukumaki Y, Nawata H, Okano H . A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia. Leukemia 1990; 4: 365–372.

    CAS  PubMed  Google Scholar 

  64. Kamesaki H, Michaud GY, Irving SG, Suwabe N, Kamesaki S, Okuma M, Cossman J . TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1. Blood 1996; 87: 999–1005.

    CAS  PubMed  Google Scholar 

  65. Komiyama A, Kawai H, Miyagawa Y, Akabane T . Childhood lymphoblastic leukemia with natural killer activity: Establishment of the leukemia cell lines retaining the activity. Blood 1982; 60: 1429–1436.

    CAS  PubMed  Google Scholar 

  66. Klingemann HG, Gong HJ, Maki G, Horsman DE, Dalal BI, Phillips GL . Establishment and characterization of a human leukemic cell line (SR-91) with features suggestive of early progenitor cell origin. Leuk Lymphoma 1994; 12: 463–470.

    CAS  PubMed  Google Scholar 

  67. Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, Rovera G . Growth factor requirements of childhood acute leukemia: Establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192–199.

    CAS  PubMed  Google Scholar 

  68. Rush J, Heinonen K, Mrozek K, Wolf BJ, Abdel-Rahman M, Szymanska J, Peltomaki P, Kapadia F, Bloomfield CD, Caligiuri MA, Plass C . Comprehensive cytogenetic and molecular genetic characterization of the TI–1 acute myeloid leukemia cell line reveals cross-contamination with K–562 cell line. Blood 2002; 99: 1874–1876.

    PubMed  Google Scholar 

  69. Taoka T, Tasaka T, Tanaka T, Irino S, Norman AW . Characterization, growth, and differentiation of a human myeloid leukemia cell line, TI-1 cell. Blood 1992; 80: 46–52.

    CAS  PubMed  Google Scholar 

  70. Juneja HS, Rajaraman S, Ramsey KM, Elder FFB . Role of bone marrow stromal cells in the establishment of a transformed lymphoblastic B-cell line from a normal human subject. Leukemia Res 1986; 10: 1209–1219.

    CAS  Google Scholar 

  71. Al-Katib A, Abubakr Y, Mohamed A, Maki A, Diuric Z, Mohammad R . Multiple mechanisms of drug resistance in anaplastic large cell lymphoma. Blood 1994; 84: 638a.

    Google Scholar 

  72. Drexler HG, Quentmeier H, Dirks WG, Uphoff CC, MacLeod RAF . DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL). Leukemia 2002; 16: 1868–1870.

    CAS  PubMed  Google Scholar 

  73. Mohammad RM, Mohamed AN, Hamdan MY, Vo T, Chen B, Katato K, Abubakr YA, Dugan MC, Al-Katib A . Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model. Leukemia 1996; 10: 130–137.

    CAS  PubMed  Google Scholar 

  74. Hamamoto Y, Nagai K, Muto M, Nakamura K, Yasui H, Asagami C . Establishment and characterization of a novel human cell line exhibiting both immunophenotypic markers of monocyte/macrophage and natural killer cell lineage from peripheral blood of a patient with atopic dermatitis. Exp Dermatol 1997; 6: 49–53.

    CAS  PubMed  Google Scholar 

  75. Hamamoto Y, Nagai K, Muto M, Furumoto H, Mogami S, Asagami C . Establishment and characterization of a novel human promonocytic cell line from peripheral blood of a patient with psoriasis. Arch Dermatol Res 1996; 288: 225–229.

    CAS  PubMed  Google Scholar 

  76. Yamaguchi Y, Nishio H, Kasahara T, Ackerman SJ, Koyanagi J, Suda T . Models of lineage switching in hematopoietic development: a new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential. Leukemia 1998; 12: 1430–1439.

    CAS  PubMed  Google Scholar 

  77. Menezes J, Leibold W, Klein G, Clements G . Establishment and characterization of an Epstein–Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt’s lymphoma. Biomedicine 1975; 22: 276–284.

    CAS  PubMed  Google Scholar 

  78. Cheng T, Erickson-Miller CL, Li C, Cardier J, Wang Y, Dempsey J, Mogle M, Barbera E, Murphy MJ Jr & Dai W . HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation. Leukemia 1995; 9: 1257–1263.

    CAS  PubMed  Google Scholar 

  79. Abo J, Inokuchi K, Dan K, Nomura T . p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Blood 1993; 82: 2829–2836.

    CAS  PubMed  Google Scholar 

  80. Karpas A, Hayhoe FG, Greenberger JS, Barker CR, Cawley JC, Lowenthal RM, Moloney WC . The establishment and cytological, cytochemical and immunological characterisation of human haemic cell lines: evidence for heterogeneity. Leukemia Res 1977; 1: 35–49.

    Google Scholar 

  81. Andersson BS, Bergheim USR, Collins VP, Childs C, Beran M, Sen S, Arden K, Pathak S, Siciliano MJ, Öst A, Freireich EJ . KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp Hematol 1992; 20: 361–367.

    CAS  PubMed  Google Scholar 

  82. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC (eds). DSMZ Catalogue of Human and Animal Cell Lines, 8th edn, DSMZ: Braunschweig, Germany (2001.

    Google Scholar 

  83. Otsuki T, Wada H, Nakazawa N, Taniwaki M, Kouguchi K, Ohkura M, Uehira K, Isoda K, Yata K, Sakaguchi H, Yawata Y, Ueki A, Yamada O . Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM,carrying t(11;14) and t(8;14). Leuk Lymphoma 2001; 42: 761–774.

    CAS  PubMed  Google Scholar 

  84. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C . Hodgkin’s disease: establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol 1981; 101: 111–124.

    CAS  PubMed  Google Scholar 

  85. Morgan DA, Gumucio DL, Brodsky I . Granulocyte–macrophage colony-stimulating factor-dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 1991; 78: 2860–2871.

    CAS  PubMed  Google Scholar 

  86. Morgan DA, Class R, Soslau G, Brodsky I . Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3. Exp Hematol 1997; 25: 1378–1385.

    CAS  PubMed  Google Scholar 

  87. Hassan HT, Petershofem E, Lux E, Fonatsch C, Heil G, Freund M . Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture. Ann Hematol 1995; 71: 111–117.

    CAS  PubMed  Google Scholar 

  88. Nagai M, Seki S, Kitahara T, Abe T, Minato K, Watanabe S, Shimoyama M . A novel human myelomonocytoid cell line, P39/TSUGANE, derived from overt leukemia following myelodysplastic syndrome. Gann 1984; 75: 1100–1107.

    CAS  PubMed  Google Scholar 

  89. Bradley TR, Pilkington G, Garson M, Hodgson GS, Kraft N . Cell lines derived from a human myelomonocytic leukaemia. Br J Haematol 1982; 51: 595–604.

    CAS  PubMed  Google Scholar 

  90. Moore GE, Woods LK, Minowada J, Mitchen JR . Establishment of leukemia cell line with T cell characteristics In Vitro. 1973; 8: 434.

  91. Skinnider LF, Pabello P, Zheng CY . Characteristics of a cell line established from a case of acute megakaryoblastic leukemia. Acta Haematol 1997; 98: 26–31.

    CAS  PubMed  Google Scholar 

  92. Tange T, Nakahara K, Mitani K, Yamasaki I, Yasuda H, Tanaka F, Mizuguchi M, Oda H, Yatomi Y, Takanashi R, Fujioka S, Yamaguchi K, Urano Y . Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis. Cancer Res 1988; 48: 6137–6144.

    CAS  PubMed  Google Scholar 

  93. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y . Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte–macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991; 51: 341–348.

    CAS  PubMed  Google Scholar 

  94. Drewinko B, Mars W, Minowada J, Burk KH, Trujillo JM . ARH–77, an established human IgG-producing myeloma cell line. I. Morphology, B-cell phenotypic marker profile, and expression of Epstein–Barr virus. Cancer 1984; 54: 1883–1892.

    CAS  PubMed  Google Scholar 

  95. Pellat-Deceunynk C, Amiot M, Bataille R, Van Riet I, Van Camp B, Omede P, Boccadoro M . Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood 1995; 86: 4001–4002.

    CAS  Google Scholar 

  96. Harris NL, Gang DL, Quay SC, Poppema S, Zamecnik PC, Nelson-Rees WA, O‘Brien SI . Comtamination of Hodgkin’s disease cell cultures. Nature 1981; 289: 228–230.

    CAS  PubMed  Google Scholar 

  97. Long JC, Zamecnik PC, Aisenberg AC, Atkins L . Tissue culture studies in Hodgkin’s disease. Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors. J Exp Med 1977; 145: 1484–1500.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Goldstein M, Hoxie J, Zembryki D, Matthews D, Levinson AI . Phenotypic and functional analysis of B cell lines from patients with multiple myeloma. Blood 1985; 66: 444–446.

    CAS  PubMed  Google Scholar 

  99. Arnstein P, Taylor DO, Nelson-Rees WA, Huebner RJ, Lennette EH . Propagation of human tumors in antithymocyte serum-treated mice. J Natl Cancer Inst 1974; 52: 71–84.

    CAS  PubMed  Google Scholar 

  100. Fahey JL, Buell DN, Sox HC . Proliferation and differentiation of lymphoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann NY Acad Sci 1971; 190: 221–234.

    CAS  PubMed  Google Scholar 

  101. Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K . Characteristics of Hodgkin’s disease-derived cell lines. Cancer Treat Rep 1982; 66: 615–632.

    CAS  PubMed  Google Scholar 

  102. Drexler HG . Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 1993; 9: 1–26.

    CAS  PubMed  Google Scholar 

  103. Ritts RE Jr, Ruiz-Arguelles A, Weyl KG, Bradley AL, Weihmeir B, Jacobsen DJ, Strehlo BL . Establishment and characterization of a human non-secretory plasmacytoid cell line and its hybridization with human B cells. Int J Cancer 1983; 31: 133–141.

    PubMed  Google Scholar 

  104. Moore GE, Grace JT Jr, Citron P, Gerner R, Burns A . Leukocyte cultures of patients with leukemia and lymphomas. NY State J Med 1966; 66: 2757–2764.

    CAS  Google Scholar 

  105. Friend C, Marovitz W, Henle G, Henle W, Tsuei D, Hirschhorn K, Holland JG, Cuttner J . Observations on cell lines derived from a patient with Hodgkin’s disease. Cancer Res 1978; 38: 2581–2591.

    CAS  PubMed  Google Scholar 

  106. McCarty TM, Rajaraman S, Elder FF, Gadson P, Thompson EB . Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome. Blood 1987; 70: 1665–1672.

    CAS  PubMed  Google Scholar 

  107. Farnen JP, Tyrkus M, Hanson CA, Cody RL, Emerson SG . Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro. Leukemia 1991; 5: 574–584.

    CAS  PubMed  Google Scholar 

  108. Drexler HG, Matsuo Y . Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leukemia Res 2000; 24: 681–703.

    CAS  Google Scholar 

  109. Drexler HG, MacLeod RAF, Borkhardt A, Janssen JWG . Recurrent chromosomal translocations and fusion genes in leukemia–lymphoma cell lines. Leukemia 1995; 9: 480–500.

    CAS  PubMed  Google Scholar 

  110. Wlodarska I, Aventin A, Ingles-Esteve J, Falzetti D, Criel A, Cassiman JJ, Mecucci C, Van den Berghe H, Marynen P . A new subtype of pre-B acute lymphoblastic leukemia with t(5;12) (q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood 1997; 89: 1716–1722.

    CAS  PubMed  Google Scholar 

  111. Broad W, Wade N (eds). Betrayers of the Truth. Fraud and Deceit in Science, Oxford University Press: Oxford (1985.

    Google Scholar 

  112. Masters JRW . Human cancer cell lines: Fact and fantasy. Nature Rev Mol Cell Biol 2000; 1: 233–236.

    CAS  Google Scholar 

  113. Masters JR, Thompson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG . Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 2001; 98: 8012–8017.

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Stacey GN, Masters JRW, Hay RJ, Drexler HG, MacLeod RAF, Freshney RI . Cell contamination leads to inaccurate data: We must take action now. Nature 2000; 403: 356.

    CAS  PubMed  Google Scholar 

  115. Drexler HG, Matsuo Y . Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia 1999; 13: 835–842.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human and Animal Cell Cultures, DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany

    H G Drexler, W G Dirks & R A F MacLeod

  2. Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Okayama, Japan

    Y Matsuo

Authors
  1. H G Drexler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W G Dirks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R A F MacLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drexler, H., Dirks, W., Matsuo, Y. et al. False leukemia–lymphoma cell lines: an update on over 500 cell lines. Leukemia 17, 416–426 (2003). https://doi.org/10.1038/sj.leu.2402799

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402799

Keywords

This article is cited by

Search

Advanced search

Quick links